Angelini Pharma S.p.A. has agreed to acquire Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) for $31.50 per share in cash, valuing the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Mergers and Acquisitions